Cargando…
Immune Checkpoint Inhibitor-Induced Colitis: How Long Does the Threat Last?
Delayed immune-related events (DIRE) occur after ≥90 days of discontinuation of immunotherapy. Pembrolizumab is a monoclonal antibody that targets the programmed cell death protein 1 (PD-1) receptor of lymphocytes and is used frequently in the management of multiple cancers. Immunotherapy-related ad...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10355134/ https://www.ncbi.nlm.nih.gov/pubmed/37476113 http://dx.doi.org/10.7759/cureus.40627 |